Empower Clinics Inc.
EPWCF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.01 | 0.48 |
| FCF Yield | -57.93% | -557.68% | -6.25% | -0.66% |
| EV / EBITDA | -4.78 | -33.44 | 12.40 | -148.58 |
| Quality | ||||
| ROIC | 97.15% | 315.06% | -379.71% | 77.90% |
| Gross Margin | 4.00% | 59.19% | 47.26% | 21.22% |
| Cash Conversion Ratio | 0.22 | 0.26 | -0.75 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | 25.28% | 35.91% | 24.86% | 9.65% |
| Free Cash Flow Growth | -439.07% | 94.05% | 20.17% | -53.51% |
| Safety | ||||
| Net Debt / EBITDA | -4.00 | -33.31 | 1.72 | -1.22 |
| Interest Coverage | -4.55 | -3.36 | -5.02 | -1.91 |
| Efficiency | ||||
| Inventory Turnover | 0.76 | 1.05 | 1.12 | 1.51 |
| Cash Conversion Cycle | -241.07 | -176.69 | -70.43 | -102.02 |